MedPath
HSA Approval

Lukakline Chewable Tablet 4mg

SIN14330P

Lukakline Chewable Tablet 4mg

Lukakline Chewable Tablet 4mg

March 21, 2013

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS PHARMA PTE LTD
Licence HolderZYFAS PHARMA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, CHEWABLE

ORAL

Medical Information

R03DC03

montelukast

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

Dr. Reddy's Laboratories Limited FTO-III

Active Ingredients

Montelukast sodium 4.16mg eqv. Montelukast

4 mg

Montelukast

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Lukakline Chewable Tablet 4mg - HSA Approval | MedPath